GeraldVincentMcMahonMD

Hospital Medicine/Hospitalist

Internal Medicine/Faculty Hospitalist-St Joseph's Hospital, Syracuse

Dr. McMahon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
182 Intrepid LN
Brighton Medical Associates
Syracuse, NY 13205
Phone+1 315-218-7020

Fax+1 315-218-7050

CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2011

PubMed

16 citations
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
Diego Alvarado, Gwenda F. Ligon, Jay S. Lillquist, Scott Seibel, Gerald J. Wallweber
Plos One. 2017-07-19
22 citations
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.
Cheryl A. London, Heather L. Gardner, Sarah B. Rippy, G. S. Post, Krista M. D. La Perle
Clinical Cancer Research. 2017-05-15
3 citations
Antitumor Properties of an IgG2-Enhanced Next-Generation MET Monoclonal Antibody That Degrades Wild-Type and Mutant MET Receptors
Yan Yang, Sreekala Mandiyan, Brett S. Robinson, Gerald McMahon
Cancer Research. 2016-10-01

Harpoon Therapeutics Reports Clinical Progress Across All Four TriTAC® Pipeline Development ProgramsDecember 8th, 2020
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateNovember 4th, 2020